Studying Cuba's Lung Cancer Vaccine in the United States 

Roswell Park Cancer Institute has launched a clinical trial studying the Cuban lung cancer vaccine, CIMAvax-EGF. The clinical trial is the first of its kind in the United States. Dr. Grace Dy, Thoracic Oncologist at Roswell Park and Principal Investigator of the cancer vaccine, explains the science behind the two-part clinical trial. Learn more: goo.gl/wR15dE
Plans for phase I/II: 0:00
How the vaccine works: 2:14
Possible side effects of the vaccine: 3:07
Vaccine eligibility requirements: 5:10
Compassionate use: 6:21
Location and length of the clinical trial: 6:37
The cost of CIMAvax: 7:42